Tech Company Financing Transactions

CircuLite Funding Round

CircuLite, operating out of Saddle Brook, raised $30 million from Forbion Capital Partners and private investors.

Transaction Overview

Company Name
Announced On
11/30/2011
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors

Forbion Capital Partners (Lead Investor) (Martien van Osch)

Proceeds Purpose
Proceeds from the Series D financing will support the anticipated European commercial launch of the Synergy® circulatory support system for patients with Class IIIb and early Class IV heart failure, pending the receipt of CE Mark approval anticipated in the first half of 2012. The Series D funding will also support the U.S. clinical development of Synergy from a pilot IDE study through the initiation of a pivotal trial, and will enable CircuLite to initiate a first-in-human study in Europe with an endovascular system.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
250 Pehle Ave. Park 80 West 403
Saddle Brook, NJ 07663
USA
Email Address
Overview
CircuLite is a cardiovascular device company, focused on developing minimally-invasive micro-pumps to treat chronic heart failures.
Profile
CircuLite LinkedIn Company Profile
Social Media
CircuLite Company Twitter Account
Company News
CircuLite News
Facebook
CircuLite on Facebook
YouTube
CircuLite on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Doug Godshall
  Doug Godshall LinkedIn Profile  Doug Godshall Twitter Account  Doug Godshall News  Doug Godshall on Facebook
Chief Financial Officer
Peter McAree
  Peter McAree LinkedIn Profile  Peter McAree Twitter Account  Peter McAree News  Peter McAree on Facebook
Chief Medical Officer
Katrin Leadley
  Katrin Leadley LinkedIn Profile  Katrin Leadley Twitter Account  Katrin Leadley News  Katrin Leadley on Facebook
Chief Scientific Officer
Jeffrey LaRose
  Jeffrey LaRose LinkedIn Profile  Jeffrey LaRose Twitter Account  Jeffrey LaRose News  Jeffrey LaRose on Facebook
VP - General Counsel
Larry Knopf
  Larry Knopf LinkedIn Profile  Larry Knopf Twitter Account  Larry Knopf News  Larry Knopf on Facebook
VP - R & D
Mark Strong
  Mark Strong LinkedIn Profile  Mark Strong Twitter Account  Mark Strong News  Mark Strong on Facebook
VP - Regulatory Affairs
Bob Yocher
  Bob Yocher LinkedIn Profile  Bob Yocher Twitter Account  Bob Yocher News  Bob Yocher on Facebook
VP - Sales
Jim Schuermann
  Jim Schuermann LinkedIn Profile  Jim Schuermann Twitter Account  Jim Schuermann News  Jim Schuermann on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/30/2011: AcuFocus venture capital transaction
Next: 11/30/2011: Objective Logistics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary